Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Zolmitriptan 2.5 mg oral tablet |
Is a |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
|
Product containing zolmitriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
|
Zolmitriptan 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
|
Zolmitriptan zmt 2.5mg disintegrating tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
|
Zolmitriptan 2.5mg oro-dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
|
Zomig 5mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
|
Zolmitriptan 5mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
|
Zolmitriptan 2.5 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
|
Zolmitriptan 5 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
|
Product containing zolmitriptan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing zolmitriptan in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing only zolmitriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 5 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 5 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 2.5 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan 2.5 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely zolmitriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely zolmitriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing zolmitriptan in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |
Zolmitriptan only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan (substance) |
Inferred relationship |
Some |
1 |